During the past decade, May Women's Health Clinic conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "May Women's Health Clinic" are "Hot Flashes" (1 trials) and "Overactive Bladder" (1 trials). Many other conditions were trialed in "May Women's Health Clinic" in a lesser frequency.

Most popular intervention types in "May Women's Health Clinic" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Fesoterodine 4mg" (1 trials), "Fesoterodine 8mg" (1 trials), "Gabapentin Extended-Release (G-ER) 1200 mg" (1 trials) and "Gabapentin Extended-Release (G-ER) 1800 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "May Women's Health Clinic" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "May Women's Health Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in May Women's Health Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in May Women's Health Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".